Cardiovascular Adverse Event Risk Following a COPD Exacerbation
In the first 30 days following an exacerbation of chronic obstructive pulmonary disease, there is an increased risk of cardiovascular adverse events.
All articles by Britt Gambino
Mechanically Ventilated Patients With COPD May Benefit From Early Tracheostomy
Researchers conducted a retrospective analysis of patients with COPD who were hospitalized and mechanically ventilated.
Dupilumab Associated With Reduced Severe Outpatient Asthma Exacerbation Rates
In patients with type 2 asthma, dupilumab was associated with significantly lower annualized outpatient asthma exacerbation rates and lower total number of days using systemic corticosteroids.
Expired or Previously Used N95 Respirator Masks: Fitted Filtration Efficiencies Evaluated
Expired or previously used and sterilized N95 respirators can be used when new N95 respirators are unavailable during the COVID-19 pandemic.
Novel Rapid Influenza Diagnostic Test Demonstrates Good Sensitivity, Specificity
The Theraflu Home FluTest, a novel rapid influenza diagnostic test, demonstrated good sensitivity and specificity for both influenza A and B viruses.
Managing Chronic Headache During the COVID-19 Pandemic: A Q&A
Matthew Robbins, MD, author of “COVID-19 and headache: a primer for trainees,” details how care has changed for patients with chronic headaches in the midst of the COVID-19 pandemic.
Tobacco Smoke Exposure Limits Benefits of CFTR Modulators in Cystic Fibrosis
Tobacco smoke exposure inhibited the therapeutic benefit of the cystic fibrosis transmembrane conductance regulator modulators in pediatric patients.
Lower Calculated Lung Cancer Risk in Black Patients Eligible for Screening
Compared with white patients, black patients with screen-detected cancers had a lower calculated lung cancer risk, despite having a significantly higher mean 6-year lung cancer risk.
Lopinavir-Ritonavir Does Not Offer Substantial Benefit in Severe COVID-19
In patients who were hospitalized with severe coronavirus disease, treatment with lopinavir-ritonavir did not provide a substantial benefit beyond standard care.
Dupilumab May Lower Exacerbation Rates in Allergic Bronchopulmonary Aspergillosis
In a post hoc analysis of the LIBERTY ASTHMA QUEST study, researchers found that dupilumab may reduce exacerbations in patients with allergic bronchopulmonary aspergillosis.
